Delivery Order SPE2DB25D3006-SPE2DB25FXHYM
- Not listed
- The Defense Logistics Agency (DLA) awarded a $1,331.11 firm fixed-price delivery order to AmerSourceBergen Drug Corp on January 20, 2026, for the supply of Concerta ER 36 mg tablets (100 count). This non-set-aside award, with performance completion scheduled for January 21, 2026, represents a task order executed under AmerSourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,309.47 to AmerSourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units) on January 20, 2026, with completion scheduled for January 21, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Concerta ER Tablets 36mg, with a ceiling value of $1,849.39. This firm fixed-price, non-set-aside contract was awarded on June 6, 2025, with an ultimate completion date of June 9, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order serves as a child contract under the company's existing...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $5,413.32 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,564,287,331 units of the pharmaceutical product Concerta ER 36 mg tablets. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support Department of...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for 100 tablets of Concerta ER 27 mg, valued at $1,815.45. The award, issued on December 1, 2025, with a completion date of December 2, 2025, represents a firm fixed-price delivery under a non-set-aside competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract executed under the company's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Concerta ER Tablets 36mg, with a ceiling value of $3,409.05 and an ultimate completion date of April 25, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 30, 2025, for the supply of Concerta ER 18 mg tablets (100-count units) with a contract value of $5,679.26. The award is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and represents a non-competitive set-aside contract. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,180.56 firm fixed-price contract is for the delivery of Concerta ER 36 mg tablets, with a final completion date of January 23, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Concerta ER 36 mg tablets (100-count units) valued at $11,257.85. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by July 15, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,957.42 to AmerisourceBergen Drug Corp for the supply of Concerta ER 54 mg tablets (100-unit quantity) on January 14, 2026, with an ultimate completion date of January 15, 2026. This firm fixed-price contract, which involves no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora,...
- SPE2DB25D3006Indefinite Delivery Contract
- SPE2DB25D3006-SPE2DB25FXHYMDelivery Order
AmerSourceBergen Drug Corp was awarded a delivery order valued at $2,208.66 by the Defense Logistics Agency (DLA) on April 24, 2025, for the supply of Concerta ER 36 mg tablets (100-count packages). The contract is a firm fixed price delivery order with an ultimate completion date of April 25, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation and represents a child contract under AmerSourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerSourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a comprehensive $999,999,999.00 indefinite delivery vehicle (SPE2DX) with DLA Troop Support Medical that extends through December 2026. This prime contract serves as the underlying vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The current delivery order for Concerta ER—a medication used to treat attention-deficit/hyperactivity disorder—exemplifies the routine pharmaceutical procurement activities executed under this expansive contract framework to meet federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 4/24/25 |